Immunoglobulin G fusion proteins (Wyeth)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameImmunoglobulin G fusion proteins (Wyeth)
Drug Alias NameGL50-IgGB7.2-IgG
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunoglobulin G agonists
TargetsImmunoglobulin G
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth BioPharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth BioPharma
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A